Texas A&M

March 7, 2013 — Ultrasound technology could soon experience a significant upgrade that would enable it to produce high-quality, high-resolution images, thanks to the development of a new key material by a team of researchers that includes a professor in the department of biomedical engineering at Texas A&M University.

March 7, 2013 — A newly identified genetic variant doubles the risk of calcium buildup in the heart’s aortic valve. Calcium buildup is the most common cause of aortic stenosis, a narrowing of the aortic valve that can lead to heart failure, stroke and sudden cardiac death.

March 7, 2013 — Experts from The Children's Hospital of Philadelphia were among the leaders of two large national studies showing that extending cardiopulmonary resuscitation (CPR) longer than previously thought useful saves lives in both children and adults. The research teams analyzed the impact of CPR duration in patients who suffered cardiac arrest while hospitalized.

MobileDemand and VectraCor Inc. have partnered to provide a turnkey solution to the healthcare industry for patients presenting with chest pain to detect real-time ECG changes suggestive of a heart attack. VectraCor has chosen the xTablet C1200 rugged convertible to use as their mobile, rugged version of the VectraplexECG System.

March 7, 2013 — Philips Healthcare announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its EchoNavigator live image-guidance tool.

An echocardiogram being performed on a patient using a Toshiba ultrasound system at ASE 2017. ASE offers appropriate use criteria (AUC) for echocardiograms.

The American Society of Echocardiography (ASE) has released a list of five interventions whose appropriateness physicians and patients should discuss as part of Choosing Wisely, an initiative of the ABIM Foundation, along with Consumer Reports. First in the list, they ask that patients and their doctors talk about the real need for additional echocardiograms when there are only minor signs of heart valve leakage.

CardioNet Inc. announced a multi-year development agreement with the Belgium-based nanoelectronics research center IMEC and its Dutch affiliate Holst Centre. Over the next 18 months, the companies will work to develop two revolutionary cardiac monitoring products.

 Mercator MedSystems Inc. announced it has received CE mark approval to market its Cricket and Bullfrog Micro-Infusion Catheters in Europe, significantly expanding the market for these products, which have previously received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The Mercator micro-infusion catheters are capable of non-systemic delivery of therapeutic agents directly across any peripheral or coronary blood vessel. Initially, these products will be commercialized for the treatment of peripheral artery disease (PAD), a critical health issue affecting 12-14 percent of the general population and nearly 20 percent of those over the age of 70. Approximately 23 million Western Europeans and 17 million Americans have PAD.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now